Department of Psychosomatic Internal Medicine, Kagoshima University Graduate School of Medical and Dental Sciences Kagoshima, Japan.
Front Neurosci. 2013 Apr 8;7:51. doi: 10.3389/fnins.2013.00051. eCollection 2013.
Obesity and diabetes mellitus are great public health concerns throughout the world because of their increasing incidence and prevalence. Leptin, the adipocyte hormone, is well known for its role in the regulation of food intake and energy expenditure. In addition to the regulation of appetite and satiety that recently has attracted much attentions, insight has also been gained into the critical role of leptin in the control of the insulin-glucose axis, peripheral glucose and insulin responsiveness. Since the discovery of leptin, leptin has been taken for its therapeutic potential to obesity and diabetes. Recently, the therapeutic effects of central leptin gene therapy have been reported in insulin-deficient diabetes in obesity animal models such as ob/ob mise, diet-induced obese mice, and insulin-deficient type 1 diabetes mice, and also in patients with inactivating mutations in the leptin gene. Herein, we review the role of leptin in regulating feeding behavior and glucose metabolism and also the therapeutic potential of leptin in obesity and diabetes mellitus.
肥胖症和糖尿病是全世界面临的重大公共卫生问题,因为它们的发病率和患病率不断上升。瘦素是一种脂肪细胞激素,它在调节食物摄入和能量消耗方面的作用是众所周知的。除了最近备受关注的食欲和饱腹感调节作用外,人们还深入了解了瘦素在控制胰岛素-葡萄糖轴、外周葡萄糖和胰岛素反应性方面的关键作用。自从瘦素被发现以来,人们一直认为它具有治疗肥胖症和糖尿病的潜力。最近,在肥胖动物模型(如 ob/ob 小鼠、饮食诱导肥胖小鼠和胰岛素缺乏 1 型糖尿病小鼠)和瘦素基因失活突变的患者中,中枢性瘦素基因治疗对胰岛素缺乏性糖尿病的治疗效果已经得到了报道。本文综述了瘦素在调节摄食行为和葡萄糖代谢中的作用,以及瘦素在肥胖症和糖尿病中的治疗潜力。